Vaccine Bioprocess Development and Commercialisation

The Modular Training for the Bioprocess Industries (MBI) programme pioneered by UCL Biochemical Engineering is a series of intensive short modules designed for professionals in the bioprocessing industry. The MBI Programme has a long history of equipping the bioprocessing industry's workforce with up-to-date skills and knowledge of process options in order to rapidly develop validatable, efficient and robust processes.

The course is designed to explore the critical issues at each stage of vaccine development. Attendees hear from international experts about the research as well as operational and regulatory challenges facing the global vaccine market. In addition to expert lectures and excellent networking opportunities with your peers, one case study will be conducted during the workshop about strategies for commercial specifications for vaccines.

Topics covered will include:

  •  Introduction to Vaccine Development with Case Studies
  • Scale-up from lab to pilot scale
  • Quality by Design (QbD) as part of vaccine development
  • Expression systems
  • Single use platforms
  • Process Development Challenges of Novel Vaccines
  • Adventitious Agent Contamination in Biomanufacturing
  • Final formulation and adjuvants
  • Regulatory Perspectives and Future Directions
  • Global Vaccine Preparedness to Respond to Future Disease Outbreaks

The cost of the course includes tuition, course materials, lunches, refreshments and a networking dinner. Accommodation is not included.